Literature DB >> 7492479

Infectious and catheter-related complications in pediatric patients treated with peritoneal dialysis at a single institution.

B Kuizon1, T L Melocoton, M Holloway, S Ingles, E W Fonkalsrud, I B Salusky.   

Abstract

Continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD) are the predominant dialytic modalities for the majority of children while awaiting transplantation. Wide acceptability of peritoneal dialysis is hindered by infectious complications. A retrospective review of 367 pediatric patients treated with CAPD/CCPD for at least 3 months from September 1980 through December 1994 revealed that the peritonitis incidence ranged from 1.7 to 0.78 episodes per patient-year. No differences in peritonitis rates were observed between patients treated with CAPD or CCPD. Gram-positive organisms were responsible for the majority of peritonitis episodes. Age, sex, race, primary renal disease, presence of nephrotic syndrome, and serum albumin level were not associated risk factors. Longer time on treatment and diminished serum IgG level were associated with increased peritonitis incidence. Treatment was successfully completed at home in most cases. Almost half of the catheter losses were caused by Staphylococcus, Pseudomonas, and fungal peritonitis and tunnel/exit-site infections. Infectious complications are still the major causes of morbidity and treatment failure in patients treated with CAPD/CCPD. Thus, controlled studies are needed to assess methods for prevention or improvement of peritonitis rates in this patient population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492479     DOI: 10.1007/bf00867677

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Update on peritoneal dialysis worldwide.

Authors:  K D Nolph
Journal:  Perit Dial Int       Date:  1993       Impact factor: 1.756

2.  A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD).

Authors:  D G Oreopoulos; M Robson; S Izatt; S Clayton; G A deVeber
Journal:  Trans Am Soc Artif Intern Organs       Date:  1978

3.  Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.

Authors:  W F Keane; C M Comty; H A Verbrugh; P K Peterson
Journal:  Kidney Int       Date:  1984-03       Impact factor: 10.612

4.  Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.

Authors:  V L Yu; A Goetz; M Wagener; P B Smith; J D Rihs; J Hanchett; J J Zuravleff
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

5.  Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children.

Authors:  T von Lilien; I B Salusky; I Boechat; R B Ettenger; R N Fine
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

6.  Analysis of complications in a chronic peritoneal dialysis pediatric patient population. The Italian Registry of Pediatric Chronic Peritoneal Dialysis.

Authors:  E Verrina; S Bassi; F Perfumo; A Edefonti; G Zacchello; B Andreetta; I Pela; R Penza; G Piaggio; M Picca
Journal:  Perit Dial Int       Date:  1993       Impact factor: 1.756

7.  Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.

Authors:  S W Zimmerman; E Ahrens; C A Johnson; W Craig; J Leggett; M O'Brien; L Oxton; E B Roecker; S Engeseth
Journal:  Am J Kidney Dis       Date:  1991-08       Impact factor: 8.860

Review 8.  Continuous peritoneal dialysis for children: a decade of worldwide growth and development.

Authors:  S R Alexander; M Honda
Journal:  Kidney Int Suppl       Date:  1993-02       Impact factor: 10.545

9.  Peritonitis during continuous ambulatory peritoneal dialysis in children.

Authors:  A R Watson; A Vigneux; R M Bannatyne; J W Balfe
Journal:  CMAJ       Date:  1986-05-01       Impact factor: 8.262

10.  Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.

Authors:  A Fattom; R Schneerson; D C Watson; W W Karakawa; D Fitzgerald; I Pastan; X Li; J Shiloach; D A Bryla; J B Robbins
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.609

View more
  4 in total

1.  Chronic peritoneal dialysis in children: catheter related complications. A single centre experience.

Authors:  Francesco Macchini; Alberto Valadè; Gianluigi Ardissino; Sara Testa; Alberto Edefonti; Maurizio Torricelli; Sergio Luzzani
Journal:  Pediatr Surg Int       Date:  2006-05-16       Impact factor: 1.827

2.  Epidemiology and outcomes of peritonitis in children on peritoneal dialysis in Australasia.

Authors:  Esmeralda B Bordador; David W Johnson; Paul Henning; Sean E Kennedy; Stephen P McDonald; John R Burke; Steven J McTaggart
Journal:  Pediatr Nephrol       Date:  2010-09       Impact factor: 3.714

3.  Risk factors for catheter-related complications in pediatric peritoneal dialysis.

Authors:  Khawla A Rahim; Kristy Seidel; Ruth A McDonald
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

4.  Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at Severance Hospital.

Authors:  Kyong Ok Lee; Se Jin Park; Ji Hong Kim; Jae Seung Lee; Pyung Kil Kim; Jae Il Shin
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.